BUY Glenmark Pharmaceuticals — Prakash Gaba, 14 Aug 2026

byPrakash GabaHorizon: NA (inferred Intraday)14 Aug 2026, 6:48 pm ISTvia CNBC Awaaz.

Entry₹1,950Stated

Target₹2,000

Stop loss₹1,900-2.56% risk

Exit—No position was opened

ExpiredNA

Follow Prakash Gaba for new calls(20% target hit, 251 closed calls)Get alerts Watch GLENMARK for new buy/sell callsGet alerts See 3 active Intraday calls on GLENMARK See 17 active Intraday picks this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 17 Aug 2026

1 supporting1 neutral1 opposing

Supports the BUY call (1)

2 advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·14 Aug · 3d ago

Neutral / worth noting (1)

Glenmark USA has agreed to a settlement of $15.28 million to resolve antitrust and consumer protection lawsuits related to price-fixing allegations. The company denies all allegations and states the s

BSE · Company Update·11 Aug · 5d ago

Weighs against the BUY call (1)

Glenmark Pharma US arm agrees to $15.28 million settlement with Humana over antitrust lawsuits

NewsCnbc-Tv18·12 Aug · 5d ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.